Steris PLC (NYSE:STE) VP Karen L. Burton sold 1,500 shares of the company’s stock in a transaction dated Tuesday, February 13th. The shares were sold at an average price of $85.59, for a total transaction of $128,385.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Shares of Steris PLC (NYSE:STE) traded up $2.68 during trading on Wednesday, hitting $88.33. 468,871 shares of the stock were exchanged, compared to its average volume of 395,170. Steris PLC has a twelve month low of $67.55 and a twelve month high of $93.71. The company has a current ratio of 2.82, a quick ratio of 2.22 and a debt-to-equity ratio of 0.46. The firm has a market capitalization of $7,285.06, a price-to-earnings ratio of 30.05 and a beta of 1.22.
Steris (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.07 by $0.05. Steris had a net margin of 9.42% and a return on equity of 11.57%. The business had revenue of $661.90 million for the quarter, compared to analyst estimates of $663.17 million. During the same period in the previous year, the business posted $0.98 earnings per share. The business’s revenue was up 2.3% compared to the same quarter last year. equities analysts forecast that Steris PLC will post 4.13 EPS for the current fiscal year.
Several institutional investors have recently modified their holdings of STE. Citigroup Inc. acquired a new position in Steris during the second quarter worth about $206,000. Parametric Portfolio Associates LLC grew its position in Steris by 6.2% during the second quarter. Parametric Portfolio Associates LLC now owns 24,973 shares of the medical equipment provider’s stock worth $2,035,000 after buying an additional 1,460 shares during the period. Dimensional Fund Advisors LP grew its position in Steris by 4.3% during the second quarter. Dimensional Fund Advisors LP now owns 576,920 shares of the medical equipment provider’s stock worth $47,021,000 after buying an additional 23,793 shares during the period. Stifel Financial Corp grew its position in Steris by 14.5% during the second quarter. Stifel Financial Corp now owns 10,808 shares of the medical equipment provider’s stock worth $881,000 after buying an additional 1,370 shares during the period. Finally, State Street Corp grew its position in Steris by 53.2% during the second quarter. State Street Corp now owns 2,336,074 shares of the medical equipment provider’s stock worth $190,392,000 after buying an additional 811,622 shares during the period. Institutional investors and hedge funds own 89.47% of the company’s stock.
A number of research analysts have recently issued reports on the stock. KeyCorp reiterated a “buy” rating and set a $91.00 price target on shares of Steris in a research note on Tuesday, October 17th. Zacks Investment Research lowered shares of Steris from a “buy” rating to a “sell” rating in a research note on Monday, November 6th. TD Securities boosted their price target on shares of Steris from C$14.00 to C$16.00 and gave the stock a “buy” rating in a research note on Thursday, November 9th. Raymond James Financial reiterated a “market perform” rating and set a $100.00 price target on shares of Steris in a research note on Wednesday, January 3rd. Finally, Northcoast Research set a $102.00 price target on shares of Steris and gave the stock a “buy” rating in a research note on Thursday, February 8th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus price target of $84.80.
COPYRIGHT VIOLATION NOTICE: This report was published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/14/insider-selling-steris-plc-ste-vp-sells-1500-shares-of-stock.html.
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.